Protective effect of atorvastatin in cultured osteoarthritic chondrocytes
Open Access
- 21 July 2009
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 28 (1) , 110-115
Abstract
The aim of our study was to evaluate the in vitro effect of an HMG‐CoA reductase inhibitor, atorvastatin, on the expression of significant anabolic and catabolic genes in human osteoarthritic chondrocytes and to explore the metabolic pathways involved in this process. Human articular osteoarthritic chondrocytes were cultured in the presence and absence of atorvastatin (10 and 50 µmol/L) for 24 h. Metalloproteinase 13 (MMP‐13), collagen type II (COL2A1), and aggrecan (AGC) mRNA expression levels were evaluated by real‐time PCR, and protein expression levels by Western blot analysis. IL‐1β levels in culture medium was analyzed with ELISA. The effect of the treatment with the mevalonate isoprenoid derivatives farnesol and geranylgeraniol, or the cholesterol precursor squalene, was evaluated in the atorvastatin osteoarthritic chondrocyte cultures. Incubation of osteoarthritic chondrocyte cultures with atorvastatin produced a significant dose‐dependent reduction in IL‐1β production. Atorvastatin supplementation in cultures produced a decrease in MMP‐13 mRNA and protein expression levels, which was reversed by the addition of farnesol. Regarding AGC and COL2A1 mRNA expression, a significant increase was observed only in chondrocytes cultures treated with 50 µmol/L atorvastatin. Our findings suggest that atorvastatin may have potential chondroprotective effects mostly by reducing cartilage degradation. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:110–115, 2010Keywords
This publication has 21 references indexed in Scilit:
- Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammationOsteoarthritis and Cartilage, 2009
- Simvastatin Stimulates Chondrogenic Phenotype of Intervertebral Disc Cells Partially Through BMP-2 PathwaySpine, 2008
- Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: Effects of statins and farnesyl and geranylgeranyl transferase inhibitorsArthritis & Rheumatism, 2007
- Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disordersCardiovascular Research, 2006
- Intermolecular Differences of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Contribute to Distinct Pharmacologic and Pleiotropic ActionsThe American Journal of Cardiology, 2005
- Simvastatin reduces MMP-3 level in interleukin 1β stimulated human chondrocyte cultureAnnals of the Rheumatic Diseases, 2004
- Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytesJournal of Orthopaedic Science, 2003
- Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effectLife Sciences, 2000
- Osteoarthrosis in Patients and PopulationsBMJ, 1961